Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
3.400
+0.170 (5.26%)
At close: Jul 3, 2025, 1:00 PM
3.320
-0.080 (-2.35%)
After-hours: Jul 3, 2025, 4:03 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $36.61 million as of July 3, 2025. Its market cap has decreased by -52.74% in one year.
Market Cap
36.61M
Enterprise Value
-25.79M
1-Year Change
-52.74%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $36.61M, a decrease of -98.54%. That is a compound annual growth rate of -56.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 36.61M | -47.14% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | 2.40B | -4.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |